发明名称 |
吡唑并嘧啶酮类或吡咯并三嗪酮类衍生物、其制备方法及其在医药上的应用;PYRAZOLOPYRIMIDINONE OR PYRROLOTRIAZINONE DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOF |
摘要 |
本发明涉及吡唑并嘧啶酮类或吡咯并三嗪酮类衍生物、其制备方法及其在医药上的应用。具体而言,本发明涉及一种通式(I)所示的吡唑并嘧啶酮类或吡咯并三嗪酮类衍生物及其可药用的盐,其制备方法以及它们作为促性腺素释放激素(GnRH)受体拮抗剂特别是作为子宫内膜异位症等治疗剂的用途,其中通式(I)中的各取代基的定义与说明书中的定义相同。;The present invention relates to pyrazolopyrimidinone or pyrrolotriazinone derivatives, the preparation method and medical use thereof. Specifically, the present invention relates to a novel pyrazolopyrimidinone or pyrrolotriazinone derivative represented by formula (I), the preparation methods thereof, the pharmaceutical composition containing the same, the use of the same as a gonadotropin-releasing hormone (GnRH) receptor antagonist, especially the uses for treatment of endometriosis disease, wherein each substituent of formula (I) is as defined in the specification. |
申请公布号 |
TW201536787 |
申请公布日期 |
2015.10.01 |
申请号 |
TW103136105 |
申请日期 |
2014.10.20 |
申请人 |
上海恒瑞医药有限公司 SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. |
发明人 |
吕贺军 LU, HEJUN;孙飘扬 SUN, PIAOYANG;桂斌 GUI, BIN;董庆 DONG, QING |
分类号 |
C07D487/04(2006.01);A61K31/519(2006.01);A61K31/53(2006.01);A61P5/04(2006.01);A61P35/00(2006.01) |
主分类号 |
C07D487/04(2006.01) |
代理机构 |
|
代理人 |
洪武雄陈昭诚 |
主权项 |
|
地址 |
中国大陆 CN; |